Athersys
ATHX
#11275
Rank
NZ$1.47 M
Marketcap
NZ$0.02397
Share price
-33.50%
Change (1 day)
-98.88%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -NZ$67.38 Million

According to Athersys's latest financial reports the company's current earnings are NZ$0.08 Million. In 2022 the company made an earning of -NZ$0.14 Billion, an increase over its 2021 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$67.38 Million-50.72%
2022 -NZ$0.14 Billion-11.54%
2021 -NZ$0.16 Billion11.14%
2020 -NZ$0.14 Billion72.2%
2019 -NZ$80.76 Million77.29%
2018 -NZ$45.56 Million-22.91%
2017 -NZ$59.1 Million111.89%
2016 -NZ$27.89 Million-8.52%
2015 -NZ$30.49 Million-40.81%
2014 -NZ$51.51 Million18.62%
2013 -NZ$43.43 Million
2011 -NZ$24.47 Million19.71%
2010 -NZ$20.44 Million-26.28%
2009 -NZ$27.73 Million-18.21%
2008 -NZ$33.9 Million-8.28%
2007 -NZ$36.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.52 B-62,855.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.26 B-16,638.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.26 B-24,732.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.71 B-17,245.47%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$13.65 B-18,513.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.14 B-28,618.75%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
NZ$0.30 B-512.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$5.41 Billion 7,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-NZ$1.12 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA